RCT(randomized control trial) for effectiveness of Tranexamic acid for type II endoleak after endovascular aneurysm repair

Authors
Category Primary study
Registry of TrialsUMIN Clinical Trials Registry
Year 2015
INTERVENTION: Tranexamic acid 750 mg/day for 6 months after EVAR Non‐administration of Tranexamic acid CONDITION: Abdominal aortic aneurysm PRIMARY OUTCOME: Frequency of type II endoleak after EVAR (Number of patients) SECONDARY OUTCOME: 1 Changing aneurysm size; 2 Frequency of re‐intervention; 3 Biomarker; ; MMP‐9; IFN‐r; IL‐6; D‐dimer; FDP; PAI‐1; TGF‐B; PIC INCLUSION CRITERIA: EVAR cases for Abdominal aortic aneurysm Consent cases for this study
Epistemonikos ID: 2d54e579e5244cb8eee3b1b57b52cbb8917ae610
First added on: Aug 23, 2024